Lensar (LNSR) Change in Accured Expenses (2019 - 2026)
Lensar (LNSR) reported Change in Accured Expenses of -$3.9 million for Q1 2026, down 3853.4% year-over-year from $103000.0 in Q1 2025, and down 170.73% quarter-over-quarter from -$1.4 million in Q4 2025.
Lensar (LNSR) Change in Accured Expenses (2019 - 2026) Analysis & Trends
Lensar (LNSR) has 8 years of Change in Accured Expenses data on file, last reported at -$3.9 million in Q1 2026.
- Change in Accured Expenses for Q1 2026 came in at -$3.9 million, down 3853.4% year-over-year; the trailing twelve-month figure through Mar 2026 was -$4.3 million (down 253.22% YoY), and the FY2025 annual result was -$341000.0, down 127.97% from the prior year.
- Change in Accured Expenses slipped to -$3.9 million in Q1 2026 per LNSR's latest filing, from -$1.4 million in the prior quarter.
- Over five years, Change in Accured Expenses peaked at $2.2 million in Q3 2025 and troughed at -$3.9 million in Q1 2026.
- A 5-year average of -$117647.1 and a median of $165000.0 in 2024 frame the typical range for Change in Accured Expenses.
- The sharpest annual moves came in 2024 and 2026: Change in Accured Expenses jumped 278.57% in 2024, then tumbled 3853.4% in 2026.
- A 5-year view of Change in Accured Expenses shows it stood at -$266000.0 in 2022, then jumped by 200.0% to $266000.0 in 2023, then jumped by 278.57% to $1.0 million in 2024, then slumped by 241.81% to -$1.4 million in 2025, then sank by 170.73% to -$3.9 million in 2026.
- Business Quant data shows LNSR's Change in Accured Expenses at -$3.9 million in Q1 2026, -$1.4 million in Q4 2025, and $2.2 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | - |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | -654.00 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 703.00 Mn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | -512.00 Mn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | -347.10 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 21.07 Mn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 145.10 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | -250.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 74.30 Mn |
| 10 | Lensar | 70.05 Mn | 70.34 Mn | 6.38 Mn | -3.87 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3.87 Mn |
| Mar 31, 2026 | -3.87 Mn |
| Dec 31, 2025 | -1.43 Mn |
| Dec 31, 2025 | -1.43 Mn |
| Sep 30, 2025 | 2.17 Mn |
| Sep 30, 2025 | 2.17 Mn |
| Jun 30, 2025 | -1.18 Mn |
| Jun 30, 2025 | -1.18 Mn |
| Mar 31, 2025 | 103,000.00 |
| Mar 31, 2025 | 103,000.00 |
| Dec 31, 2024 | 1.01 Mn |
| Dec 31, 2024 | 1.01 Mn |
| Sep 30, 2024 | 1.54 Mn |
| Sep 30, 2024 | 1.54 Mn |
| Jun 30, 2024 | 165,000.00 |
| Jun 30, 2024 | 165,000.00 |
| Mar 31, 2024 | -1.49 Mn |
| Mar 31, 2024 | -1.49 Mn |
| Dec 31, 2023 | 266,000.00 |
| Dec 31, 2023 | 266,000.00 |